Q&A: Investing in Life Science
Following the DVPs first 10 investments, Emma Palmer Foster, Director of Discovery Park Ventures, and Martino Picardo, Director of DPV and Chairman of Discovery Park, share their learnings and insights into life science investing. Read more
15 Apr 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
Scotland’s Life Sciences Sector Poised for Growth
Speaking at an event in Edinburgh, Chris Dougray, Head of Development at CBRE Scotland, and Chris Williams, CBRE’s Head of Life Sciences, joined forces to examine the burgeoning sector’s place in Scotland. Read more
14 Mar 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
UK biotech company responds to approval changes and R&D tax relief
Last Thursday, chancellor Jeremy Hunt announced new measures for smoother medicine approvals in the UK, increased support for R&D, and a simplified tax system for SMEs. UK biotech company, Nevrargenics shared its position on the 2023 Budget. Read more
23 Mar 2023
Pharmaceutical Insights + Pharma Finance and Investment Insights
Why invest in pharma in times of a recession?
Léone Atayi, CEO of Hybrigenics and Stemcis, discusses the importance of investing in the pharmaceutical industry amid a recession. Read more
21 Feb 2023
Pharmaceutical Insights + Pharma Finance and Investment Insights
Smart Financing and CROs: investing in digitalisation for drug development
Sally-Anne Whybrow, healthcare business development manager, Siemens Financial Services, UK examines how smart financing can help CROs invest in financially-sustainable technology. Read more
5 Oct 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
Q&A with Lonza: Support for biotech startups
Following on from their recent partnership with Israel Biotech Fund (IBF), EPM caught up with Lonza's Pnina Weitz on the importance of early-stage support for emerging companies, and how robust strategies early on can pave a way to commercialisation. Read more
29 Jun 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
Fujifilm to Invest Additional $1.2 Billion to Expand US Manufacturing Facility
FUJIFILM Corporation have announced an investment of $1.2 billion in its Large-Scale Cell Culture CDMO Business to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility in Holly Springs, North Carolina. Read more
16 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Dot Compliance Raises $17.5 Million in Series B Extension Funding
Dot Compliance, a provider of AI-enabled Quality Management System (QMS) solutions, have announced it has raised $17.5 million in Series B extension funding, marking a significant up-round. Read more
15 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Novartis Tender Offer for MorphoSys AG Commences
Novartis published the offer document for the voluntary public takeover offer by its wholly owned subsidiary Novartis BidCo AG for all outstanding shares of MorphoSys AG. Read more
12 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Q&A: Renaissance Lakewood
In an interview with Jai McIntosh, Editor for EPM, Eric Kaneps, VP, Sales and Marketing at Renaissance Lakewood explores how innovation has been at the heart of the success of the company and the market. Read more
19 Apr 2024
Optimising Time-to-Market for Innovative Cell Therapy Trials
Didier Haguenauer, CMO, CellProthera discusses the need to optimise time-to-market for innovative cell therapies in our latest EPM Online Insight. Read more
16 Apr 2024
Mapping the Road to Seamless Scale-Up
Nandu Deorkar, Ph.D., MBA, senior vice president, research & development, biopharma production; and George Marquez, vice president, operations, Avantor, discuss advancing clinical trials manufacturing from pilot to production in our latest EPM issue. Read more
16 Apr 2024
Using Graphs in Drug Discovery to Probe Relationships
Life Sciences data expert Dr Alexander Jarasch on the learnings other R&D teams can gain from the use of graphs at the Institut de Recherches Servier for our latest EPM Online Insight. Read more
16 Apr 2024
Q&A: Investing in Life Science
Following the DVPs first 10 investments, Emma Palmer Foster, Director of Discovery Park Ventures, and Martino Picardo, Director of DPV and Chairman of Discovery Park, share their learnings and insights into life science investing. Read more
15 Apr 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
Unlocking The Potential of Africa’s Pharmaceutical Market
Magrietha Mallinson, Global Vertical Lead, Health at DP World discusses unlocking the potential of Africa's pharmaceutical market in our latest EPM Online insight. Read more
12 Apr 2024
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25